CHRONIC HYPOTENSION - IN THE SHADOW OF HYPERTENSION

被引:12
作者
ROBERTSON, D
MOSQUEDAGARCIA, R
ROBERTSON, RM
BIAGGIONI, I
机构
[1] Center for Space Physiology and Medicine, Departments of Medicine Neurology and Pharmacology, Vanderbilt University, Nashville, TN
关键词
HYPOTENSION; AUTONOMIC FAILURE; DOPAMINE-BETA-HYDROXYLASE DEFICIENCY; BARORECEPTOR DYSFUNCTION; HYPOVOLEMIA;
D O I
10.1093/ajh/5.6.200S
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Understanding the causes and treatment of chronic hypotension is of benefit to affected patients and may also shed light on the physiology and genetics of mechanisms of blood pressure control. Symptomatic hypotension (almost always with a blood pressure fall greater-than-or-equal-to 20/10 mm Hg) may reflect unrecognized medication effects or a variety of other causes. Autonomic neuropathies include those secondary to diabetes, peripheral autonomic impairment (the Bradbury-Eggleston syndrome), central autonomic impairment (the Shy-Drager syndrome), or newly described gene defects such as dopamine-beta-hydroxylase deficiency (which causes the absence of norepinephrine with an accumulation of dopamine). Baroreceptor dysfunction causes wide swings in blood pressure that are unrelated to posture, whereas a variety of stimuli (cough, micturition, or carotid sinus pressure) may precipitate paroxysmal parasympathetic activation, and sympathetic orthostatic hypotension associated with hypovolemia may occur with mitral valve prolapse or as an idiopathic condition. The differentiation of these and other causes of symptomatic hypotension may in many cases lead to beneficial therapy.
引用
收藏
页码:S200 / S205
页数:6
相关论文
共 72 条
  • [1] Blomqvist C.G., Orthostatic hypotension, Hypertension, 8, pp. 772-730, (1987)
  • [2] Bannister R., Mathias C., Testing autonomic reflexes, Autonomic Failure: A Textbook of Clin-Ical Disorders of the Autonomic Nervous System, pp. 289-307, (1988)
  • [3] Biaggioni I., Onrot J., Stewart C.K., Et al., The potent pressor effect of phenylpropanolamine in patients with autonomic impairment, JAMA, 258, pp. 236-239, (1987)
  • [4] Campbell I.W., Ewing D.J., Clarke B.F., 9-α-Fluorohydro- cortisone in the treatment of postural hypotension in diabetic autonomic neuropathy, Diabetes, 24, pp. 381-384, (1975)
  • [5] Chobanian A.V., Tifft C.P., Faxon D.P., Et al., Treatment of orthostatic hypotension with ergotamine, Circulation, 67, pp. 602-609, (1983)
  • [6] Davies B., Bannister R., Sever P., Pressor amines and monoamine oxidase inhibitors for treatment of postural hypotension in autonomic failure: Limitations and hazards, Lancet, 1, pp. 172-175, (1978)
  • [7] Davis T.A., Delafuente J.C., Orthostatic hypotension: Therapeutic alternatives for geriatric patients, DICP, 23, pp. 750-756, (1989)
  • [8] Demanet J.C., Usefulness of noradrenaline and tyramine infusion tests in the diagnosis of orthostatic hypotension, Cardiology, 61, pp. 213S-224S, (1976)
  • [9] Frick M.H., 9-Alpha-fluorohydrocortisone in the treatment of postural hypotension, Acta Med Scand, 179, pp. 293-299, (1966)
  • [10] Goldberg M.R., Hollister A.S., Robertson D., Influence of yohimbine on blood pressure, autonomic reflexes and plasma catecholamines in humans, Hypertension, 5, pp. 772-778, (1983)